MaxCyte (MXCT) Stock: Buy, Sell, or Hold?
MXCT - MaxCyte, Inc. Common Stock
$1.59
0.07 (4.97%)
▲
5d:
+10.84%
30d:
+36.64%
90d:
+56.93%
WAIT
LOW Confidence
Analysis Updated: Oct 27, 2026 12:00 AM ET
Earnings: Nov 10, 2026
13d
Get Alerted When MXCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: MXCT is 15.7% above its trading range ($1.37). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: MXCT is 15.7% above its trading range ($1.37). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: MXCT is currently trading at $1.58, which is considered extended relative to its 30-day fair value range of $1.05 to $1.37.
Technical Outlook: Technically, MXCT is in a strong downtrend. Immediate support is located at $1.20, while resistance sits at $1.64. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: MXCT scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.11 (+172.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MXCT is in a strong downtrend. Immediate support is located at $1.20, while resistance sits at $1.64. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: MXCT scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.11 (+172.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.05 -
$1.37
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price significantly overextended (+15.7% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.0%)
- BULLISH: Trading 172.0% below Wall St target ($4.11)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.05 -
$1.37
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.20
Resistance Level
$1.64
Current Trend
Strong Downtrend
Technical data as of
Oct 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.12
Wall Street Target
$4.11
(+172.0%)
Revenue Growth (YoY)
-14.5%
Profit Margin
-114.8%
Share & Embed Analysis
Last updated: October 27, 2026 2:33 PM ET
Data refreshes hourly during market hours. Next update: 3:33 PM
Data refreshes hourly during market hours. Next update: 3:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MXCT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 50 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$101 | 52 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 48 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 36 SELL |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
22 analysts |
$83 | 40 HOLD |
